Nanotechnology utilized to deliver targeted treatments for lung infection
Researchers from Massachusetts Institute of Technology (Cambridge, MA, USA) have developed a targeted antimicrobial treatment, that dramatically reduces the number of bacteria in the lungs of mice infected with Pseudomonas aeruginosa.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.